{"date":"2025-03-26","count":26,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6815-2025-03-26-2100-1a9n551","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"21:00:19","subject":"本公司所研發之膠原蛋白增生「皮下填補劑妮芙蕾」取得TFDA核發第三類醫材銷售許可證(衛部醫器製字第008439號)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-26 21:00，「本公司所研發之膠原蛋白增生「皮下填補劑妮芙蕾」取得TFDA核發第三類醫材銷售許可證(衛部醫器製字第008439號)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-26-1925-eg96ov","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"19:25:05","subject":"本公司美國子公司PhiBio Therapeutics Inc.自體細胞新藥TRK-001取得台灣衛生福利部原則同意進行預防活體腎臟移植受贈者排斥反應之二期人體臨床試驗(補充114年2月4日公告)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-26 19:25，「本公司美國子公司PhiBio Therapeutics Inc.自體細胞新藥TRK-001取得台灣衛生福利部原則同意進行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1905-1it0js","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"19:05:50","subject":"公告本公司董事會通過取得禮曼生物科技(股)公司百分之八十股權","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 19:05，「公告本公司董事會通過取得禮曼生物科技(股)公司百分之八十股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1853-11wjw0o","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:53:29","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 18:53，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1846-zs9nuh","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:46:26","subject":"公告本公司董事會決議通過辦理私募發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 18:46，「公告本公司董事會決議通過辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1845-tulf6t","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:45:00","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 18:45，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1843-nob2a5","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:43:42","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 18:43，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1843-14vofg8","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:43:07","subject":"公告本公司董事會通過113年度員工酬勞及董事酬勞分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 18:43，「公告本公司董事會通過113年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-03-26-1842-kmy10s","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:42:26","subject":"公告本公司董事會通過113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-03-26 18:42，「公告本公司董事會通過113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-26-1825-oqtv0b","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:25:30","subject":"公告本公司113年度現金增資認股基準日暨相關事宜(補充代收股款及存儲專戶行庫)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-26 18:25，「公告本公司113年度現金增資認股基準日暨相關事宜(補充代收股款及存儲專戶行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-26-1824-17q8rx7","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"18:24:31","subject":"公告本公司董事會通過民國113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-26 18:24，「公告本公司董事會通過民國113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-26-1751-bwopfv","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:51:28","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-26 17:51，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-26-1741-xvwo7x","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:41:36","subject":"公告本公司董事會決議通過113年度虧損撥補案及無分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-26 17:41，「公告本公司董事會決議通過113年度虧損撥補案及無分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-26-1725-1oj2zvc","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:25:57","subject":"代重要子公司育禾管理顧問股份有限公司公告會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-26 17:25，「代重要子公司育禾管理顧問股份有限公司公告會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-26-1725-197frt5","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:25:07","subject":"代重要子公司育禾管理顧問股份有限公司公告董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-26 17:25，「代重要子公司育禾管理顧問股份有限公司公告董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-03-26-1712-bwopfv","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:12:33","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-26","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-03-26 17:12，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-03-26-1710-100dsv9","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:10:06","subject":"公告本公司董事會決議召開114年股東常會相關事宜。","clause":"第32款","fact_date":"2025-03-26","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-03-26 17:10，「公告本公司董事會決議召開114年股東常會相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-03-26-1709-1emef6y","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"17:09:28","subject":"公告本公司董事會通過113年度財務報告。","clause":"第43款","fact_date":"2025-03-26","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-03-26 17:09，「公告本公司董事會通過113年度財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-03-26-1657-13w9o1h","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"16:57:48","subject":"本公司自主開發新成分抗癌候選新藥GNTbm-38之研究報告發表，將於2025年美國臨床腫瘤醫學會(ASCO)年會以海報形式呈現","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-03-26 16:57，「本公司自主開發新成分抗癌候選新藥GNTbm-38之研究報告發表，將於2025年美國臨床腫瘤醫學會(ASCO)年會以海報形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-03-26-1653-1p99ook","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"16:53:41","subject":"本公司董事會通過內部稽核主管任命案","clause":"第11款","fact_date":"2025-03-26","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-03-26 16:53，「本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-03-26-1636-1pb8ufa","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"16:36:46","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-03-26 16:36，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-26-1520-uxd8dv","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"15:20:01","subject":"公告本公司董事會決議召開114年股東常會(新增討論事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-26 15:20，「公告本公司董事會決議召開114年股東常會(新增討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-26-1518-13jn658","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"15:18:35","subject":"公告本公司董事會決議解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-26 15:18，「公告本公司董事會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-26-1515-1dmdgdo","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-26","time":"15:15:54","subject":"公告本公司董事會通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-26 15:15，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-03-26-1502-ezshxt","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-03-26","time":"15:02:40","subject":"公告本公司買回庫藏股數量累積達公司已發行股份總額百分之二且金額達新台幣三億元以上","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-03-26 15:02，「公告本公司買回庫藏股數量累積達公司已發行股份總額百分之二且金額達新台幣三億元以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-26-1043-1oaynm","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-26","time":"10:43:56","subject":"本公司受邀參加台新綜合證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-26 10:43，「本公司受邀參加台新綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}